Immuneering Insider Trades
NASDAQ: IMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 7 · $270.34K
- Sales
- 0 · $0
- Shares bought / sold
- 60.25K / 0
- Net activity
- Net buying $270,336
Immuneering insider activity
Over the last 12 months, Immuneering insiders reported 8 transactions on SEC Form 4: 7 open-market purchases and 0 sales. Insiders bought $270,336 and sold $0 worth of stock, for net insider buying of $270,336. The most recent filing shows Zeskind Benjamin J. (PRESIDENT AND CEO) buying 2,400 shares at $4.56 on Jun 23, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IMRX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
IMRX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 23, 2026 | Zeskind Benjamin J.PRESIDENT AND CEO | Buy | 2,400 | $10.95K | Form 4 |
| Jun 15, 2026 | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Buy | 6,035 | $25.05K | Form 4 |
| Mar 13, 2026 | Neufeld Leah RCHIEF PEOPLE OFFICER | Award | 3,628 | $15.57K | Form 4 |
| Jan 16, 2026 | Brakewood Harold EugeneChief Business Officer | Buy | 5,250 | $24.99K | Form 4 |
| Jan 15, 2026 | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Buy | 2,298 | $10.50K | Form 4 |
| Jan 15, 2026 | Schall Thomas J.Director | Buy | 21,645 | $101.04K | Form 4 |
| Jan 13, 2026 | Neufeld Leah RCHIEF PEOPLE OFFICER | Buy | 2,626 | $10.91K | Form 4 |
| Jan 12, 2026 | Feinberg PeterDirector | Buy | 20,000 | $86.90K | Form 4 |
| Oct 3, 2025 | Feinberg PeterDirector | Buy | 7,500 | $50.02K | Form 4 |
| Oct 1, 2025 | Bookman MichaelCHIEF LEGAL OFFICER, SECRETARY | Buy | 1,020 | $6.97K | Form 4 |
| Oct 1, 2025 | Neufeld Leah RCHIEF PEOPLE OFFICER | Buy | 800 | $5.10K | Form 4 |
| Oct 1, 2025 | Morales MalloryChief Accounting Officer | Buy | 300 | $1.92K | Form 4 |
| Sep 30, 2025 | Feinberg PeterDirector | Buy | 7,500 | $52.73K | Form 4 |
| Sep 29, 2025 | Feinberg PeterDirector | Buy | 5,000 | $35.90K | Form 4 |
| Sep 15, 2025 | Morales MalloryChief Accounting Officer | Award | 14,497 | $20.70K | Form 4 |
| Sep 15, 2025 | Neufeld Leah RCHIEF PEOPLE OFFICER | Award | 11,815 | $16.87K | Form 4 |
| Sep 15, 2025 | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Award | 14,880 | $21.25K | Form 4 |
| Jul 2, 2025 | Zeskind Benjamin J.PRESIDENT AND CEO | Buy | 7,015 | $24.79K | Form 4 |
| Jul 2, 2025 | Neufeld Leah RCHIEF PEOPLE OFFICER | Buy | 700 | $2.50K | Form 4 |
| Jul 2, 2025 | HAUSMAN DIANADirector | Buy | 3,000 | $10.87K | Form 4 |
| Jul 2, 2025 | HAUSMAN DIANADirector | Buy | 2,500 | $8.99K | Form 4 |
| Jul 1, 2025 | Zeskind Benjamin J.PRESIDENT AND CEO | Buy | 2,985 | $10.09K | Form 4 |
| Jun 27, 2025 | Schall Thomas J.Director | Buy | 9,500 | $34.79K | Form 4 |
| Jun 23, 2025 | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Buy | 6,007 | $14.60K | Form 4 |
| Jun 20, 2025 | Brakewood Harold EugeneChief Business Officer | Buy | 1,900 | $4.80K | Form 4 |
| Jun 20, 2025 | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Buy | 7,415 | $20.02K | Form 4 |
| Jun 18, 2025 | Zeskind Benjamin J.PRESIDENT AND CEO | Buy | 21,000 | $50.14K | Form 4 |
| Jun 18, 2025 | Feinberg PeterDirector | Buy | 25,000 | $63.19K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4